We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The review of the safety of isotretinoin has concluded.
Labelling requirements for e-liquids.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
What 'single-use' means and what symbol is used by manufacturers to show this.
Collecting and acting on information on any adverse effects of electronic cigarette devices and refill containers on human health.
Information for manufacturers and users of medical devices containing plastic with DEHP phthalates.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
How to get permission to reproduce or re-use information from MHRA.
Guidance for NHS trusts carrying out clinical trials and organisations sponsoring a trial to ensure electronic health record systems are compliant.
Updates from MHRA on the suspension of devices made by Silimed
This guidance gives information about the wording for statutory warnings for medicines containing paracetamol.
Guidance on the use and safety of bisphosphonates for bone-related conditions.
Guidance on the use and side effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs), their safety, use in pregnancy and the risk of suicidal behaviour.
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system
MHRA review of levothyroxine products in response to concerns about potential inconsistencies of different products.
Guidance for manufacturers on the regulations that apply to prosthetic, orthotic and ophthalmic devices.
These Regulations (which come into force immediately before exit day) are made to correct drafting defects and omissions in the Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775) and the Medical…
Guidance for healthcare professionals on using benchtop sterilizers safely and effectively.
What you need to do to supply investigational medicinal products (IMPs) from Great Britain to Northern Ireland.
Guidance to help medicine manufacturers meet safe limits on levels of nitrosamine impurities in medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).